Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiying Qiu

Showing results (161-170 of 194) with videos related to

Pageof 20
Sort By:
Frontiers in Immunology|July 11, 2022
Comparison of Haploidentical Hematopoietic Stem Cell Transplant With or Without Unrelated Cord Blood Infusion in Severe Aplastic Anemia: Outcomes of a Multicenter StudyMeiqing Lei, Yanming Zhang, Wenjing Jiao, et al.
Journal of Hematology & Oncology|February 13, 2014
FISH+CD34+CD38- cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcomeLibing Wang, Lei Gao, Sheng Xu, et al.
Annals of Hematology|July 9, 2024
Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignanciesYanlu Du, Ying Zhang, Xiaowei Xu, et al.
Haematologica|September 2, 2011
Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemiaQian Wang, Huiying Qiu, Hui Jiang, et al.
Cell Transplantation|November 26, 2022
Low-Dose Anti-Thymocyte Globulin Plus Low-Dose Posttransplant Cyclophosphamide as an Effective Regimen for Prophylaxis of Graft <i>Versus</i> Host Disease After Haploidentical Peripheral Blood Stem Cell Transplantation With Maternal/Collateral Related DonorsTing Li, Qiaomei He, Jun Yang, et al.
Frontiers in Oncology|February 4, 2022
Comparable Outcomes and Health-Related Quality of Life for Severe Aplastic Anemia: Haploidentical Combined With a Single Cord Blood Unit <i>vs</i> Matched Related TransplantsMeiqing Lei, Xiaoli Li, Yanming Zhang, et al.
Transplantation and Cellular Therapy|March 31, 2021
Early T-Cell Precursor Acute Lymphoblastic Leukemia and T/Myeloid Mixed Phenotype Acute Leukemia Possess Overlapping Characteristics and Both Benefit From CAG-Like Regimens and Allogeneic Hematopoietic Stem Cell TransplantationSining Liu, Qingya Cui, Haiping Dai, et al.
Frontiers in Cellular and Infection Microbiology|June 2, 2022
Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning RegimenYuhua Ru, Jinjin Zhu, Tiemei Song, et al.
Bone Marrow Transplantation|February 19, 2020
Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomesYuhua Ru, Xiang Zhang, Tiemei Song, et al.
Pediatric Investigation|September 30, 2024
Nutritional status and neurodevelopmental levels in infants at high risk of cerebral palsyHongyu Zhou, Huiying Qiu, Xiaoyue Wang, et al.
Pageof 20

Showing results (161-170 of 194) with videos related to

Sort By:
Pageof 20
Frontiers in Immunology|July 11, 2022
Comparison of Haploidentical Hematopoietic Stem Cell Transplant With or Without Unrelated Cord Blood Infusion in Severe Aplastic Anemia: Outcomes of a Multicenter StudyMeiqing Lei, Yanming Zhang, Wenjing Jiao, et al.
Journal of Hematology & Oncology|February 13, 2014
FISH+CD34+CD38- cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcomeLibing Wang, Lei Gao, Sheng Xu, et al.
Annals of Hematology|July 9, 2024
Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignanciesYanlu Du, Ying Zhang, Xiaowei Xu, et al.
Haematologica|September 2, 2011
Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemiaQian Wang, Huiying Qiu, Hui Jiang, et al.
Cell Transplantation|November 26, 2022
Low-Dose Anti-Thymocyte Globulin Plus Low-Dose Posttransplant Cyclophosphamide as an Effective Regimen for Prophylaxis of Graft <i>Versus</i> Host Disease After Haploidentical Peripheral Blood Stem Cell Transplantation With Maternal/Collateral Related DonorsTing Li, Qiaomei He, Jun Yang, et al.
Frontiers in Oncology|February 4, 2022
Comparable Outcomes and Health-Related Quality of Life for Severe Aplastic Anemia: Haploidentical Combined With a Single Cord Blood Unit <i>vs</i> Matched Related TransplantsMeiqing Lei, Xiaoli Li, Yanming Zhang, et al.
Transplantation and Cellular Therapy|March 31, 2021
Early T-Cell Precursor Acute Lymphoblastic Leukemia and T/Myeloid Mixed Phenotype Acute Leukemia Possess Overlapping Characteristics and Both Benefit From CAG-Like Regimens and Allogeneic Hematopoietic Stem Cell TransplantationSining Liu, Qingya Cui, Haiping Dai, et al.
Frontiers in Cellular and Infection Microbiology|June 2, 2022
Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning RegimenYuhua Ru, Jinjin Zhu, Tiemei Song, et al.
Bone Marrow Transplantation|February 19, 2020
Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomesYuhua Ru, Xiang Zhang, Tiemei Song, et al.
Pediatric Investigation|September 30, 2024
Nutritional status and neurodevelopmental levels in infants at high risk of cerebral palsyHongyu Zhou, Huiying Qiu, Xiaoyue Wang, et al.
Pageof 20